Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

GE HealthCare Technologies Inc.

Healthcare US GEHC

62.03USD
0.04(0.06%)

Last update at 2026-06-03T20:20:00Z

Day Range

60.7362.11
LowHigh

52 Week Range

64.6289.69
LowHigh

Fundamentals

  • Previous Close 61.99
  • Market Cap32971.53M
  • Volume4222122
  • P/E Ratio15.88
  • Dividend Yield0.19%
  • EBITDA3642.00M
  • Revenue TTM20625.00M
  • Revenue Per Share TTM45.23
  • Gross Profit TTM 8247.00M
  • Diluted EPS TTM4.55

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 2768.00M 2581.00M 2361.00M 2512.00M 2875.00M
Minority interest -70.00000M -57.00000M -46.00000M -51.00000M -46.00000M
Net income 2084.00M 1993.00M 3104.00M 1916.00M 2247.00M
Selling general administrative 4150.00M 4269.00M 4282.00M 3631.00M 3563.00M
Selling and marketing expenses - - - - -
Gross profit 8247.00M 8205.00M 7922.00M 7179.00M 7174.00M
Reconciled depreciation 578.00M 580.00M 610.00M 633.00M 625.00M
Ebit 3207.00M 3086.00M 2435.00M 2522.00M 2795.00M
Ebitda 3785.00M 3666.00M 2435.00M 3222.00M 3540.00M
Depreciation and amortization 578.00M 580.00M 610.00M 700.00M 745.00M
Non operating income net other - - - - -
Operating income 2762.00M 2625.00M 2435.00M 2522.00M 2795.00M
Other operating expenses 17863.00M 17047.00M 17117.00M 15819.00M 14790.00M
Interest expense 450.00M 505.00M 542.00M 77.00M 40.00M
Tax provision 614.00M 531.00M 743.00M 563.00M 600.00M
Interest income 41.00M - 26.00M - 34.00M
Net interest income -399.00000M -505.00000M -516.00000M -77.00000M -6.00000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 614.00M 531.00M -743.00000M 563.00M 600.00M
Total revenue 20625.00M 19672.00M 19552.00M 18341.00M 17585.00M
Total operating expenses 5485.00M 5580.00M 5487.00M 4657.00M 4379.00M
Cost of revenue 12378.00M 11467.00M 11630.00M 11162.00M 10411.00M
Total other income expense net 6.00M -44.00000M -74.00000M -10.00000M 80.00M
Discontinued operations - - - 18.00M 18.00M
Net income from continuing ops 2154.00M 2050.00M 1618.00M 1949.00M 2275.00M
Net income applicable to common shares - - - 1916.00M 2247.00M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 36906.00M 33089.00M 32454.00M 27539.00M 26308.00M
Intangible assets 1130.00M 1078.00M 1253.00M 1520.00M 1847.00M
Earning assets - - - - -
Other current assets 81.00M 311.00M 61.00M 417.00M 88.00M
Total liab 26307.00M 24436.00M 25144.00M 18177.00M 9632.00M
Total stockholder equity 10379.00M 8447.00M 7133.00M 9357.00M 16655.00M
Deferred long term liab - - - 82.00M 77.00M
Other current liab 5347.00M 2692.00M 3000.00M 2336.00M 2247.00M
Common stock 5.00M 5.00M 5.00M 11235.00M 17692.00M
Capital stock 5.00M 5.00M 5.00M 0.00000M 17692.00M
Retained earnings 5281.00M 3262.00M 1326.00M - -
Other liab - - - 2240.00M 2324.00M
Good will 13489.00M 13136.00M 12936.00M 12813.00M 12892.00M
Other assets 4003.00M 1509.00M 3302.00M 2534.00M 1993.00M
Cash 4512.00M 2890.00M 2494.00M 1445.00M 554.00M
Cash and equivalents - - - - -
Total current liabilities 9105.00M 9553.00M 8981.00M 7191.00M 6761.00M
Current deferred revenue - 1943.00M 1918.00M 1896.00M 1864.00M
Net debt 5491.00M 6486.00M 7369.00M 6804.00M -117.00000M
Short term debt 508.00M 1617.00M 1116.00M 15.00M 110.00M
Short long term debt 508.00M 1502.00M 1006.00M 15.00M 6.00M
Short long term debt total 10003.00M 9376.00M 9863.00M 8249.00M 437.00M
Other stockholder equity 6481.00M 6559.00M 6493.00M 18801.00M -1037.00000M
Property plant equipment - - - 2314.00M 2235.00M
Total current assets 10701.00M 9516.00M 9410.00M 8318.00M 7000.00M
Long term investments 351.00M 373.00M 357.00M 322.00M 341.00M
Net tangible assets - - - -4976.00000M 1916.00M
Short term investments - 15.00M - - -
Net receivables 3955.00M 4376.00M 4254.00M 4301.00M 3791.00M
Long term debt 9495.00M 7449.00M 8436.00M 8234.00M 31.00M
Inventory 2234.00M 1939.00M 1960.00M 2155.00M 1946.00M
Accounts payable 3250.00M 3022.00M 2947.00M 2944.00M 2540.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -1388.00000M -1379.00000M -691.00000M -1878.00000M -1037.00000M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 233.00M 1531.00M 1524.00M 702.00M 286.00M
Deferred long term asset charges - - - - -
Non current assets total 22202.00M 23573.00M 23044.00M 19221.00M 19308.00M
Capital lease obligations 460.00M 425.00M 421.00M 386.00M 400.00M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -118.00000M -914.00000M -558.00000M -398.00000M -1761.00000M
Change to liabilities - - - 619.00M 242.00M
Total cashflows from investing activities -1047.00000M -914.00000M -558.00000M -398.00000M -1761.00000M
Net borrowings 968.00M -423.00000M 1139.00M 8204.00M -12.00000M
Total cash from financing activities 617.00M -573.00000M -478.00000M -822.00000M -263.00000M
Change to operating activities - - - -81.00000M 251.00M
Net income 2154.00M 2050.00M 1618.00M 1949.00M 2275.00M
Change in cash 1622.00M 387.00M 1055.00M 890.00M -451.00000M
Begin period cash flow 2893.00M 2506.00M 1451.00M 561.00M 1012.00M
End period cash flow 4515.00M 2893.00M 2506.00M 1451.00M 561.00M
Total cash from operating activities 1988.00M 1951.00M 2101.00M 2113.00M 1607.00M
Issuance of capital stock - - - - -
Depreciation 578.00M 580.00M 610.00M 633.00M 625.00M
Other cashflows from investing activities -447.00000M -160.00000M 24.00M -92.00000M -47.00000M
Dividends paid 64.00M 55.00M 41.00M - -
Change to inventory -142.00000M -81.00000M 111.00M -402.00000M -435.00000M
Change to account receivables -216.00000M -150.00000M -171.00000M -231.00000M -1336.00000M
Sale purchase of stock -200.00000M 0.00000M 0.00000M - -
Other cashflows from financing activities -123.00000M -128.00000M -1576.00000M -819.00000M -246.00000M
Change to netincome - - - -341.00000M 13.00M
Capital expenditures 482.00M 401.00M 387.00M 310.00M 248.00M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -357.00000M -59.00000M 22.00M -256.00000M -1370.00000M
Stock based compensation 130.00M 125.00M 114.00M - -
Other non cash items -517.00000M -1276.00000M -1006.00000M -776.00000M -523.00000M
Free cash flow 1506.00M 1550.00M 1714.00M 1803.00M 1359.00M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
GEHC
GE HealthCare Technologies Inc.		 0.04 0.06% 62.03 15.88 14.62 1.60 3.26 1.93 10.51
ABT
Abbott Laboratories		 0.02 0.02% 86.99 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 1.70 0.58% 295.00 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 4.20 5.69% 77.95 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 0.01 0.02% 47.69 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth for the development of AI-powered breast cancer screening solutions. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

GE HealthCare Technologies Inc.

500 West Monroe Street, Chicago, IL, United States, 60661

Key Executives

Name Title Year Born
Mr. Peter J. Arduini President, CEO & Director 1965
Mr. James K. Saccaro VP & CFO 1973
Dr. Taha Kass-Hout M.D., M.S. Chief Science & Technology Officer 1972
Mr. Frank R. Jimenez Esq. VP, General Counsel & Corporate Secretary 1965
Mr. Jan Makela President & CEO of Imaging 1969
Mr. George Andrew Newcomb Controller & Chief Accounting Officer 1967
Mr. Jahid Khandaker Chief Information Officer NA
Ms. Carolynne Borders Chief Investor Relations Officer NA
Ms. Rana Strellis Chief Corporate Marketing & Communications Officer NA
Mr. Thomas J. Westrick President & CEO of Patient Care Solutions 1969

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.